Dr Carmen Escuriola Ettingshausen is the Director of the Haemophilia Centre Rhein Main - HZRM, Frankfurt, Germany. She graduated in medicine at the Johann Wolfgang Goethe-University in Frankfurt from 1985 to 1992. After that, she became resident at the comprehensive care centre for Thrombosis and Haemostasis of the Children´s Hospital at University Hospital of Frankfurt in the department of Paediatrics until 1996, and obtained the Doctor title in 1995. She performed specialist´s training in Paediatrics at the University Hospital of Frankfurt from 1996 until 2000, and since then she was a staff member at the comprehensive care centre for Thrombosis and Haemostasis of the University Hospital of Frankfurt, department of Paediatrics until 2012. In 2012 she founded the Haemophilia Centre Rhein-Main. Dr Escuriola-Ettingshausen’s clinical interests include haemorrhagic disorders with a focus on haemophilia, thrombosis, congenital immunodeficiencies, and hereditary angioedema in both paediatric and adult patients. Her research interests are haemorrhagic disorders, particularly in treatment of people with haemophilia and those in treatment with inhibitors. Moreover, she is member of the German, Swiss and Austrian Society for Thrombosis and Haemostasis Research (GTH), International Society for Thrombosis and Haemostasis (ISTH) and the International Prophylaxis Study Group (IPSG).

Dr Carmen Escuriola Ettingshausen has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Bayer Healthcare, Biomarin, Biotest, CSL Behring, Grifols, Kedrion, LFB, NovoNordisk, Octapharma, Pfizer, Roche/Chugai, Sanofi, Sobi, Takeda.​